Add a listing
    Add a listing

    Leucadia Therapeutics

      restoring cerebrospinal fluid to treat Alzheimer's disease

    General
    • Headquarters

      Riverside, California, United States

    • Founders & Team

      Doug Ethell

    • Year Founded

      2015

    • Company type

      Private company

    • Investors

      Methuselah Fund

    Technical Details
    • Disease indication

      Alzheimer's disease

    • Product modality

      small molecule drugs

    • Product names

      Arethusta

    About

    Led by Founder and CEO Doug Ethell, Leucadia Therapeutics has looked at Alzheimer's disease with new eyes. We have assembled an amazing team of dedicated professionals who are focused on CURING Alzheimer’s disease.

    This mission-oriented team discovered a major trigger for Alzheimer’s disease pathology and has developed a patented strategy to correct that condition.

    How much is an extra decade of life worth to you? Make a bet on longevity science today.

    Donate to Impetus Grants

    You May Also Be Interested In